Core Viewpoint - The article discusses the ongoing price war in the aesthetic medicine market, particularly focusing on the "童颜针" (youthful needle) products, highlighting the conflict between upstream material suppliers and downstream clinics, with New Oxygen's pricing strategy causing significant market disruption [2][4][39]. Group 1: Market Dynamics - New Oxygen's self-operated clinic is selling the "艾维岚" (Aivilan) product at 5,999 yuan, which is one-third of the market price of 18,000 yuan, leading to dissatisfaction from the brand owner, Changchun Shengboma [2][12]. - The price war is intensifying as more competitors enter the market, with at least seven "童颜针" products now approved for sale in China, compared to only two in 2021 [32][36]. - The market for "童颜针" is projected to grow from 1.488 billion USD in 2024 to 2.082 billion USD by 2033, indicating significant potential for growth despite current pricing pressures [29]. Group 2: Company Strategies - New Oxygen has established a strategic partnership with Oriental Yanmei, securing exclusive rights to commercialize several upcoming products, including the XH301 "童颜针" [6][21]. - Oriental Yanmei's XH301 is expected to complete its domestic listing review in the second half of the year, with the company currently facing a projected revenue of only 0.13 million yuan for 2024 and a loss of 0.64 million yuan [9][19]. - The company plans to adopt an agency sales model rather than direct sales, which is seen as a safer approach given its current financial situation [20][25]. Group 3: Product Development - The XH301 product, which utilizes a combination of PLLA and CMC, is designed to stimulate collagen regeneration and improve skin tightness, with a reported effectiveness rate of 95.5% in correcting severe wrinkles [18]. - The competitive landscape is challenging for XH301, as it faces pricing pressures from existing products and the potential for lower-priced alternatives to emerge [38][44]. - Oriental Yanmei is also exploring overseas markets for its products, which may provide additional growth opportunities amid domestic competition [48][50].